Breaking News Instant updates and real-time market news.

AMRS

Amyris

$3.46 /

+0.58 (+20.14%)

12:11
08/08/19
08/08
12:11
08/08/19
12:11

Amyris jumps 20% after CBD partner LAVVAN hires former MedReleaf exec as CEO

Shares bio-science firm Amyris are soaring in early trading after its cannabinoid partner LAVVAN announced announced that Neil Closner, formerly of MedReleaf, has been appointed its new CEO. Joining Closner are several key members of MedReleaf's former leadership team who were responsible for its groundbreaking achievements and success. Former LAVVAN CEO, Etan Bendheim, will become President of the company. LAVVAN, in its collaboration with Amyris, will produce cannabidiol ,CBD,and other cannabinoids through fermentation-based technology in food-grade manufacturing facilities. LAVVAN's processes will ensure product purity and consistency for commercial-grade, cannabinoid-based products, while minimizing production costs. Shares of Amyris are up 21% or 61c to $3.48 in midday trading.

  • 27

    Aug

AMRS Amyris
$3.46 /

+0.58 (+20.14%)

02/05/19 H.C. Wainwright
H.C. Wainwright reiterates $11 target on Amyris after $255M cannabinoid deal
12/31/18 H.C. Wainwright
Amyris news today a 'significant near-term milestone,' says H.C. Wainwright
12/07/18 H.C. Wainwright
Amyris financing removes 'important overhang,' says H.C. Wainwright
11/14/18 H.C. Wainwright
Amyris price target lowered to $11 from $15 at H.C. Wainwright

TODAY'S FREE FLY STORIES

General news
FX Update: The narrow trade-weighted USD index edged out a one-week high » 02:45
08/11/20
08/11
02:45
08/11/20
02:45

FX Update: The narrow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Asian Market Update: » 01:50
08/11/20
08/11
01:50
08/11/20
01:50

Asian Market Update:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Barings BDC to hold a conference call » 21:34
08/10/20
08/10
21:34
08/10/20
21:34
BBDC

Barings BDC

$8.29 /

+0.06 (+0.73%)

, MVC

MVC Capital

$6.76 /

+0.17 (+2.58%)

Conference call to…

Conference call to discuss definitive merger agreement whereby MVC Capital will merge with and into Barings BDC will be held on August 11 at 11 am. Webcast Link

ShowHide Related Items >><<
MVC MVC Capital
$6.76 /

+0.17 (+2.58%)

BBDC Barings BDC
$8.29 /

+0.06 (+0.73%)

BBDC Barings BDC
$8.29 /

+0.06 (+0.73%)

06/24/20 Raymond James
Barings BDC upgraded to Strong Buy from Outperform at Raymond James
06/24/20 Raymond James
Barings BDC upgraded to Strong Buy from Outperform at Raymond James
05/04/20 Compass Point
Barings BDC upgraded to Buy following valuation markdowns at Compass Point
05/04/20 Compass Point
Barings BDC upgraded to Buy from Neutral at Compass Point
MVC MVC Capital
$6.76 /

+0.17 (+2.58%)

03/25/20 Maxim
PennantPark, Garrison Capital, MVC Capital cut to Hold at Maxim
03/25/20 Maxim
MVC Capital downgraded to Hold from Buy at Maxim
BBDC Barings BDC
$8.29 /

+0.06 (+0.73%)

Downgrade
Esperion downgraded to Neutral from Outperform at Credit Suisse » 21:11
08/10/20
08/10
21:11
08/10/20
21:11
ESPR

Esperion

$36.98 /

-1.01 (-2.66%)

Credit Suisse analyst…

Credit Suisse analyst Martin Auster downgraded Esperion to Neutral from Outperform with a price target of $45, down from $83. The analyst contends that the company requires a "stronger capital position" to support the achievement of profitability. While Esperion management has alluded to an ex-US partnership later this year, Auster notes that he does not see that as being sufficient to support the US business to profitability without additional capital.

ShowHide Related Items >><<
ESPR Esperion
$36.98 /

-1.01 (-2.66%)

ESPR Esperion
$36.98 /

-1.01 (-2.66%)

05/07/20 Citi
Esperion price target raised to $56 from $46 at Citi
04/20/20 JMP Securities
JMP reiterates $191 price target on Esperion after Japan partnership
04/16/20 Northland
Esperion price target lowered to $42 from $60 at Northland
04/01/20
Fly Intel: Top five analyst initiations
ESPR Esperion
$36.98 /

-1.01 (-2.66%)

ESPR Esperion
$36.98 /

-1.01 (-2.66%)

ESPR Esperion
$36.98 /

-1.01 (-2.66%)

Recommendations
Adverum Biotechnologies price target raised to $30 from $25 at Piper Sandler » 21:02
08/10/20
08/10
21:02
08/10/20
21:02
ADVM

Adverum Biotechnologies

$18.72 /

+0.23 (+1.24%)

Piper Sandler analyst…

Piper Sandler analyst Tyler Van Buren raised the firm's price target on Adverum Biotechnologies to $30 from $25 and keeps an Overweight rating on the shares after the company provided an "earlier than anticipated" update for all four cohorts in the ongoing OPTIC trial for ADVM-022. The analyst notes that there continues to be a "nice response" between the high dose with a 100% reduction in injections relative to the low dose showing an 87% reduction. Van Buren adds that the initial cohort 4 safety for ADVM-022 also appears to be "promising".

ShowHide Related Items >><<
ADVM Adverum Biotechnologies
$18.72 /

+0.23 (+1.24%)

ADVM Adverum Biotechnologies
$18.72 /

+0.23 (+1.24%)

07/08/20 Cantor Fitzgerald
Adverum Biotechnologies price target raised to $36 from $21 at Cantor Fitzgerald
06/29/20 Piper Sandler
Adverum Biotechnologies should be bought on selloff, says Piper Sandler
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
06/26/20 Raymond James
Adverum Biotechnologies downgraded to Underperform at Raymond James
ADVM Adverum Biotechnologies
$18.72 /

+0.23 (+1.24%)

  • 12
    Feb
ADVM Adverum Biotechnologies
$18.72 /

+0.23 (+1.24%)

Earnings
Adverum Biotechnologies reports Q2 EPS (36c), consensus (28c) » 20:59
08/10/20
08/10
20:59
08/10/20
20:59
ADVM

Adverum Biotechnologies

$18.72 /

+0.23 (+1.24%)

Cash, cash equivalents…

Cash, cash equivalents and short-term investments were $280.1 million as of June 30, 2020, compared to $166.0 million as of December 31, 2019. Adverum expects this quarter-end cash position to fund operations into 2022.

ShowHide Related Items >><<
ADVM Adverum Biotechnologies
$18.72 /

+0.23 (+1.24%)

ADVM Adverum Biotechnologies
$18.72 /

+0.23 (+1.24%)

07/08/20 Cantor Fitzgerald
Adverum Biotechnologies price target raised to $36 from $21 at Cantor Fitzgerald
06/29/20 Piper Sandler
Adverum Biotechnologies should be bought on selloff, says Piper Sandler
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
06/26/20 Raymond James
Adverum Biotechnologies downgraded to Underperform at Raymond James
ADVM Adverum Biotechnologies
$18.72 /

+0.23 (+1.24%)

  • 12
    Feb
ADVM Adverum Biotechnologies
$18.72 /

+0.23 (+1.24%)

Hot Stocks
Adverum Biotechnologies' ADVM-022 trial yields positive results in cohorts 1-4 » 20:58
08/10/20
08/10
20:58
08/10/20
20:58
ADVM

Adverum Biotechnologies

$18.72 /

+0.23 (+1.24%)

Adverum Biotechnologies…

Adverum Biotechnologies announced positive new interim data from Cohorts 1-4 of the OPTIC Phase 1 clinical trial of ADVM-022 intravitreal injection gene therapy in patients requiring frequent anti-VEGF injections for their wet age-related macular degeneration, or AMD. For the first time, interim data from all four cohorts of the OPTIC trial including preliminary safety data from Cohort 4, are presented. These data further demonstrate the "transformative potential of ADVM-022" to greatly reduce the treatment burden for patients with wet AMD.

ShowHide Related Items >><<
ADVM Adverum Biotechnologies
$18.72 /

+0.23 (+1.24%)

ADVM Adverum Biotechnologies
$18.72 /

+0.23 (+1.24%)

07/08/20 Cantor Fitzgerald
Adverum Biotechnologies price target raised to $36 from $21 at Cantor Fitzgerald
06/29/20 Piper Sandler
Adverum Biotechnologies should be bought on selloff, says Piper Sandler
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
06/26/20 Raymond James
Adverum Biotechnologies downgraded to Underperform at Raymond James
ADVM Adverum Biotechnologies
$18.72 /

+0.23 (+1.24%)

  • 12
    Feb
ADVM Adverum Biotechnologies
$18.72 /

+0.23 (+1.24%)

Recommendations
Magnite offers 'encouraging commentary on linearity, CTV', sayst Truist » 20:47
08/10/20
08/10
20:47
08/10/20
20:47
MGNI

Magnite

$7.11 /

+0.005 (+0.07%)

Truist analyst Matthew…

Truist analyst Matthew Thornton keeps his Buy rating and $7 price target on Magnite after its Q2 earnings beat and above-consensus guidance. The analyst is citing "encouraging" commentary from the company management on Linearity, Connected TV, and identifier for advertisers - or IDFA - which he does not expect to be a "material headwind".

ShowHide Related Items >><<
MGNI Magnite
$7.11 /

+0.005 (+0.07%)

Downgrade
Consolidated Edison downgraded to Sector Weight from Overweight at KeyBanc » 20:40
08/10/20
08/10
20:40
08/10/20
20:40
ED

Consolidated Edison

$75.39 /

+0.29 (+0.39%)

KeyBanc downgraded…

KeyBanc downgraded Consolidated Edison to Sector Weight from Overweight.

ShowHide Related Items >><<
ED Consolidated Edison
$75.39 /

+0.29 (+0.39%)

08/10/20
Fly Intel: Top five analyst upgrades
08/10/20 Credit Suisse
Consolidated Edison upgraded to Neutral from Underperform at Credit Suisse
07/15/20 Mizuho
Consolidated Edison price target lowered to $73.50 from $78 at Mizuho
07/02/20 Morgan Stanley
Consolidated Edison price target lowered to $71 from $77 at Morgan Stanley
ED Consolidated Edison
$75.39 /

+0.29 (+0.39%)

ED Consolidated Edison
$75.39 /

+0.29 (+0.39%)

Earnings
Magnite reports Q2 EPS (10c), consensus (14c) » 20:38
08/10/20
08/10
20:38
08/10/20
20:38
MGNI

Magnite

$7.11 /

+0.005 (+0.07%)

Reports Q2 revenue…

Reports Q2 revenue $42.3M, consensus $37.9M. "We are pleased to see a meaningful recovery in revenue across our entire business, specifically with the pace of year over year growth in CTV to start the third quarter. This follows our first full post-merger quarter creating an industry leading CTV and full service SSP. Programmatic ad-supported CTV is benefiting from the acceleration of cord cutting, buyers wanting more flexibility and control of their spend, inventory growth and overall consumer adoption rates," said Michael G. Barrett, President and CEO of Magnite. "Going to market as the leading independent omnichannel supply-side platform, newly branded as Magnite, puts us in a strong position to best serve buyer and publisher needs. We are seeing a number of positive drivers including sustained recovery in brand spending, supply path optimization share gains, a return of live sports, a pickup in political spending in CTV specifically, and spend re-allocation due to social advertising boycotts."

Earnings
Notable companies reporting before tomorrow's open » 20:25
08/10/20
08/10
20:25
08/10/20
20:25
SYY

Sysco

$60.13 /

+2.32 (+4.01%)

, LITE

Lumentum

$88.17 /

-3.11 (-3.41%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Lumentum (LITE), consensus 82c... Sysco (SYY), consensus (30c).

ShowHide Related Items >><<
SYY Sysco
$60.13 /

+2.32 (+4.01%)

LITE Lumentum
$88.17 /

-3.11 (-3.41%)

SYY Sysco
$60.13 /

+2.32 (+4.01%)

08/06/20 Credit Suisse
Sysco assumed with an Outperform at Credit Suisse
06/24/20 JPMorgan
Sysco price target raised to $57 from $54 at JPMorgan
06/05/20
Fly Intel: Top five analyst upgrades
06/05/20 Wells Fargo
Sysco upgraded to Overweight from Equal Weight at Wells Fargo
LITE Lumentum
$88.17 /

-3.11 (-3.41%)

07/28/20 Raymond James
Corning results provide read-through to optical names, says Raymond James
07/24/20 JPMorgan
Lumentum price target raised to $94 from $90 at JPMorgan
07/23/20 Loop Capital
Lumentum initiated with a Buy at Loop Capital
07/02/20 MKM Partners
Lumentum price target raised to $107 from $96 at MKM Partners
SYY Sysco
$60.13 /

+2.32 (+4.01%)

LITE Lumentum
$88.17 /

-3.11 (-3.41%)

SYY Sysco
$60.13 /

+2.32 (+4.01%)

LITE Lumentum
$88.17 /

-3.11 (-3.41%)

SYY Sysco
$60.13 /

+2.32 (+4.01%)

LITE Lumentum
$88.17 /

-3.11 (-3.41%)

SYY Sysco
$60.13 /

+2.32 (+4.01%)

LITE Lumentum
$88.17 /

-3.11 (-3.41%)

Periodicals
WHP Global bows out of race for Brooks Brothers, WSJ says » 20:13
08/10/20
08/10
20:13
08/10/20
20:13
SPG

Simon Property

$65.44 /

+3.34 (+5.38%)

WHP Global has exited the…

WHP Global has exited the race to buy out Brooks Brothers, leaving Simon Property Group (SPG) and a venture backed by apparel-licensing firm Authentic Brands Group, The Wall Street Journal's Soma Biswas reports, citing people familiar with the matter. Authentic Brands-Simon venture, had bid $305M for Brooks Brothers last month, the report states. Reference Link

ShowHide Related Items >><<
SPG Simon Property
$65.44 /

+3.34 (+5.38%)

SPG Simon Property
$65.44 /

+3.34 (+5.38%)

07/01/20 Goldman Sachs
Simon Property resumed with a Buy at Goldman Sachs
06/18/20 JPMorgan
Simon Property price target lowered to $90 from $145 at JPMorgan
06/17/20 Deutsche Bank
Taubman Centers named short-term sell idea at Deutsche Bank
06/11/20 Deutsche Bank
Simon Property price target raised to $100 from $97 at Deutsche Bank
SPG Simon Property
$65.44 /

+3.34 (+5.38%)

SPG Simon Property
$65.44 /

+3.34 (+5.38%)

SPG Simon Property
$65.44 /

+3.34 (+5.38%)

SPG Simon Property
$65.44 /

+3.34 (+5.38%)

Hot Stocks
Titan Medical confirms Nasdaq listing deficiency notice » 20:02
08/10/20
08/10
20:02
08/10/20
20:02
TMDI

Titan Medical

$0.84 /

+0.0258 (+3.19%)

Titan Medical announced…

Titan Medical announced that on August 5, 2020, the company received a deficiency notice from the Nasdaq Stock Market LLC Listing Qualifications Department that it was not in compliance with the minimum bid price requirement set forth in Nasdaq Rule 5550(a)(2) since the closing bid price for the Company's common shares listed on Nasdaq was below US$1.00 for 30 consecutive business days. The company intends to evaluate all available options to resolve this deficiency and regain compliance with Nasdaq Rule 5550(a)(2).

ShowHide Related Items >><<
TMDI Titan Medical
$0.84 /

+0.0258 (+3.19%)

TMDI Titan Medical
$0.84 /

+0.0258 (+3.19%)

03/31/20 Piper Sandler
Titan Medical price target lowered to $1 from $1.50 at Piper Sandler
12/23/19 Piper Sandler
Titan Medical price target cut to $1.50 from $2.50 at Piper Jaffray
11/18/19 Piper Sandler
Titan Medical transferred with an Overweight rating at Piper Jaffray
10/16/19 Maxim
Titan Medical downgraded to Hold from Buy at Maxim
  • 24
    Sep
Hot Stocks
Activision Blizzard's Macartney sells nearly 13,000 shares » 19:17
08/10/20
08/10
19:17
08/10/20
19:17
ATVI

Activision Blizzard

$82.26 /

-0.17 (-0.21%)

In a regulatory filing,…

In a regulatory filing, Activision Blizzard chief people officer Claudine Macartney disclosed the sale of 12,902 common shares of the company on August 6 at a price of $86.0605 per share.

ShowHide Related Items >><<
ATVI Activision Blizzard
$82.26 /

-0.17 (-0.21%)

ATVI Activision Blizzard
$82.26 /

-0.17 (-0.21%)

08/05/20 Barclays
Activision Blizzard price target raised to $98 from $90 at Barclays
08/05/20 Morgan Stanley
Activision Blizzard price target raised to $100 from $88 at Morgan Stanley
08/05/20 UBS
Activision Blizzard price target raised to $106 from $84 at UBS
08/05/20 Oppenheimer
Activision Blizzard price target raised to $95 from $75 at Oppenheimer
ATVI Activision Blizzard
$82.26 /

-0.17 (-0.21%)

ATVI Activision Blizzard
$82.26 /

-0.17 (-0.21%)

ATVI Activision Blizzard
$82.26 /

-0.17 (-0.21%)

ATVI Activision Blizzard
$82.26 /

-0.17 (-0.21%)

On The Fly
Fly Intel: After-Hours Movers » 19:15
08/10/20
08/10
19:15
08/10/20
19:15
KFRC

Kforce

$31.86 /

+1.14 (+3.71%)

, SCOR

Comscore

$3.13 /

-0.21 (-6.29%)

, GSKY

GreenSky

$6.35 /

+0.16 (+2.58%)

, JCOM

j2 Global

$60.11 /

-1.32 (-2.15%)

, NLS

Nautilus

$12.36 /

+0.36 (+3.00%)

, PRTS

CarParts.com

$13.71 /

+1.47 (+12.01%)

, ICUI

ICU Medical

$179.40 /

+2.19 (+1.24%)

, QRTEA

Qurate Retail

$11.56 /

+0.02 (+0.17%)

, IART

Integra LifeSciences

$49.42 /

+1.34 (+2.79%)

, STAY

Extended Stay America

$12.87 /

+0.12 (+0.94%)

, GO

Grocery Outlet

$44.37 /

-0.57 (-1.27%)

, TME

Tencent Music

$15.71 /

-0.305 (-1.91%)

, SPPI

Spectrum

$3.91 /

+0.07 (+1.82%)

, PFNX

Pfenex

$7.68 /

-0.66 (-7.91%)

, LGND

Ligand

$118.48 /

+0.98 (+0.83%)

, IPAR

Inter Parfums

$45.41 /

+1.73 (+3.96%)

, TLRY

Tilray

$7.97 /

+0.5 (+6.69%)

, CBAY

CymaBay

$6.90 /

+0.64 (+10.22%)

, PXLW

Pixelworks

$3.41 /

-0.045 (-1.30%)

, BKD

Brookdale Senior Living

$3.14 /

+0.125 (+4.15%)

, OMER

Omeros

$21.33 /

+7.2 (+50.96%)

, OXY

Occidental Petroleum

$16.49 /

+1.04 (+6.73%)

, AKBA

Akebia

$10.67 /

-0.27 (-2.47%)

, QLYS

Qualys

$113.09 /

-7.25 (-6.02%)

, RAMP

LiveRamp

$55.26 /

+1.765 (+3.30%)

, HALO

Halozyme

$28.66 /

-0.26 (-0.90%)

, CHMA

Chiasma

$4.78 /

+ (+0.00%)

, ZI

ZoomInfo

$43.28 /

-2.8 (-6.08%)

, IAC

IAC

$131.08 /

-1.86 (-1.40%)

, NSTG

NanoString

$34.98 /

-0.26 (-0.74%)

, NVAX

Novavax

$178.51 /

+8.54 (+5.02%)

, SSTK

Shutterstock

$57.06 /

-0.78 (-1.35%)

, BBBY

Bed Bath & Beyond

$12.67 /

+0.55 (+4.54%)

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
TME Tencent Music
$15.71 /

-0.305 (-1.91%)

TLRY Tilray
$7.97 /

+0.5 (+6.69%)

STAY Extended Stay America
$12.87 /

+0.12 (+0.94%)

SSTK Shutterstock
$57.06 /

-0.78 (-1.35%)

SPPI Spectrum
$3.91 /

+0.07 (+1.82%)

SCOR Comscore
$3.13 /

-0.21 (-6.29%)

RAMP LiveRamp
$55.26 /

+1.765 (+3.30%)

QRTEA Qurate Retail
$11.56 /

+0.02 (+0.17%)

QLYS Qualys
$113.09 /

-7.25 (-6.02%)

PXLW Pixelworks
$3.41 /

-0.045 (-1.30%)

PRTS CarParts.com
$13.71 /

+1.47 (+12.01%)

PFNX Pfenex
$7.68 /

-0.66 (-7.91%)

OXY Occidental Petroleum
$16.49 /

+1.04 (+6.73%)

OMER Omeros
$21.33 /

+7.2 (+50.96%)

NVAX Novavax
$178.51 /

+8.54 (+5.02%)

NSTG NanoString
$34.98 /

-0.26 (-0.74%)

NLS Nautilus
$12.36 /

+0.36 (+3.00%)

LGND Ligand
$118.48 /

+0.98 (+0.83%)

KFRC Kforce
$31.86 /

+1.14 (+3.71%)

JCOM j2 Global
$60.11 /

-1.32 (-2.15%)

IPAR Inter Parfums
$45.41 /

+1.73 (+3.96%)

ICUI ICU Medical
$179.40 /

+2.19 (+1.24%)

IART Integra LifeSciences
$49.42 /

+1.34 (+2.79%)

IAC IAC
$131.08 /

-1.86 (-1.40%)

HALO Halozyme
$28.66 /

-0.26 (-0.90%)

GSKY GreenSky
$6.35 /

+0.16 (+2.58%)

GO Grocery Outlet
$44.37 /

-0.57 (-1.27%)

CHMA Chiasma
$4.78 /

+ (+0.00%)

CBAY CymaBay
$6.90 /

+0.64 (+10.22%)

BKD Brookdale Senior Living
$3.14 /

+0.125 (+4.15%)

BBBY Bed Bath & Beyond
$12.67 /

+0.55 (+4.54%)

AKBA Akebia
$10.67 /

-0.27 (-2.47%)

KFRC Kforce
$31.86 /

+1.14 (+3.71%)

05/28/20 Sidoti
Kforce downgraded to Neutral from Buy at Sidoti
03/03/20 Sidoti
Kforce initiated with a Buy at Sidoti
02/10/20 Baird
Kforce price target lowered to $38 from $42 at Baird
SCOR Comscore
$3.13 /

-0.21 (-6.29%)

GSKY GreenSky
$6.35 /

+0.16 (+2.58%)

05/13/20 Truist
GreenSky price target lowered to $4 from $7 at SunTrust
05/13/20 Citi
GreenSky price target lowered to $3.50 from $4.50 at Citi
03/18/20 Citi
GreenSky downgraded to Sell from Neutral at Citi
JCOM j2 Global
$60.11 /

-1.32 (-2.15%)

07/30/20 Susquehanna
j2 Global can double from current levels, says Susquehanna
07/16/20 Piper Sandler
j2 Global shares offer 'compelling' risk/reward, says Piper Sandler
07/02/20 Baird
j2 Global short report selloff a buying opportunity, says Baird
07/01/20 William Blair
j2 Global response addresses short report concerns, says William Blair
NLS Nautilus
$12.36 /

+0.36 (+3.00%)

07/09/20 Craig-Hallum
Nautilus price target raised to $13 from $8 at Craig-Hallum
07/07/20 Truist
Nautilus price target raised to $12 from $10 at SunTrust
06/02/20 Roth Capital
Planet Fitness price target raised to $70 from $58 at Roth Capital
06/02/20 Truist
Nautilus price target raised to $10 from $8 at SunTrust
PRTS CarParts.com
$13.71 /

+1.47 (+12.01%)

05/12/20 Barrington
U.S. Auto Parts price target raised to $10 from $5 at Barrington
03/18/20 Barrington
U.S. Auto Parts selloff brings 'significant' buying opportunity, says Barrington
01/08/20 Craig-Hallum
U.S. Auto Parts initiated with a Buy at Craig-Hallum
ICUI ICU Medical
$179.40 /

+2.19 (+1.24%)

05/13/20 KeyBanc
ICU Medical price target lowered to $199 from $206 at KeyBanc
03/18/20 KeyBanc
ICU Medical upgraded to Overweight from Sector Weight at KeyBanc
11/12/19 Raymond James
ICU Medical price target raised to $203 from $185 at Raymond James
QRTEA Qurate Retail
$11.56 /

+0.02 (+0.17%)

06/10/20 Citi
Qurate Retail price target raised to $12 from $8 at Citi
04/21/20 UBS
Qurate Retail downgraded to Neutral from Buy at UBS
04/06/20 Citi
Citi wonders if Qurate Retail actions foreshadow going private deal
11/12/19 Craig-Hallum
Qurate Retail price target lowered to $16 from $24 at Craig-Hallum
IART Integra LifeSciences
$49.42 /

+1.34 (+2.79%)

07/09/20 Piper Sandler
Piper Sandler remains 'apprehensive' on Integra LifeSciences after Q2 revenue
05/27/20
Fly Intel: Top five analyst initiations
05/27/20 Citi
Integra LifeSciences initiated with a Neutral at Citi
05/21/20 Piper Sandler
Early diligence on new Tactile Systems CEO very positive, says Piper Sandler
STAY Extended Stay America
$12.87 /

+0.12 (+0.94%)

06/22/20 Barclays
Barclays upgrades DiamondRock on 'drive-to' resort exposure
06/02/20 Jefferies
Extended Stay America should outperform peers near and long-term, says Jefferies
04/22/20
Fly Intel: Top five analyst upgrades
04/22/20 BofA
Choice Hotels upgraded to Neutral from Underperform at Bofa
GO Grocery Outlet
$44.37 /

-0.57 (-1.27%)

08/04/20 Deutsche Bank
Grocery Outlet price target raised to $47 from $43 at Deutsche Bank
07/30/20 MKM Partners
Grocery Outlet initiated with a Buy at MKM Partners
07/29/20 MKM Partners
Grocery Outlet initiated with a Buy at MKM Partners
07/21/20 Goldman Sachs
Grocery Outlet price target raised to $47 from $43 at Goldman Sachs
TME Tencent Music
$15.71 /

-0.305 (-1.91%)

06/30/20 UBS
Tencent Music upgraded to Buy from Neutral at UBS
06/30/20 Citi
Tencent Music initiated with a Buy at Citi
03/18/20 Bocom
Tencent Music upgraded to Neutral from Sell at BOCOM
03/12/20 Morgan Stanley
Tencent Music upgraded to Overweight from Equal Weight at Morgan Stanley
SPPI Spectrum
$3.91 /

+0.07 (+1.82%)

08/03/20 H.C. Wainwright
Spectrum price target raised to $13 from $11 at H.C. Wainwright
07/28/20 Cantor Fitzgerald
Spectrum price target raised to $7 from $4 at Cantor Fitzgerald
04/28/20 H.C. Wainwright
Spectrum may have path forward for poziotinib in NSCLC, says H.C. Wainwright
12/27/19 B. Riley FBR
Spectrum price target lowered to $11 from $18 at B. Riley FBR
PFNX Pfenex
$7.68 /

-0.66 (-7.91%)

06/26/20 William Blair
Pfenex partner CHMP opinion 'material de-risking event,' says William Blair
06/15/20 Oppenheimer
Pfenex price target raised to $15 from $10 at Oppenheimer
06/01/20 Oppenheimer
Pfenex assumed with an Outperform at Oppenheimer
04/23/20
Fly Intel: Top five analyst initiations
LGND Ligand
$118.48 /

+0.98 (+0.83%)

08/04/20 Roth Capital
Ligand price target raised to $190 from $180 at Roth Capital
08/04/20 Barclays
Ligand price target raised to $145 from $134 at Barclays
07/14/20 Benchmark
Ligand price target raised to $155 from $135 at Benchmark
06/02/20 Craig-Hallum
Ligand stock should move higher, says Craig-Hallum
IPAR Inter Parfums
$45.41 /

+1.73 (+3.96%)

06/12/20 DA Davidson
Inter Parfums price target raised to $41 from $36 at DA Davidson
06/04/20
Fly Intel: Top five analyst downgrades
06/04/20 Credit Suisse
Inter Parfums downgraded to Neutral from Outperform at Credit Suisse
05/13/20 DA Davidson
DA Davidson upgrades Inter Parfums to Neutral on clearer cost cuts, EPS beat
TLRY Tilray
$7.97 /

+0.5 (+6.69%)

05/27/20 Roth Capital
Roth Capital sees Tilray operational moves as 'positive'
05/19/20 MKM Partners
Tilray price target raised to $8 from $5 at MKM Partners
05/12/20 Alliance Global Partners
Tilray price target lowered to $9 from $15 at Alliance Global Partners
05/12/20 Stifel
Tilray price target raised to $6.50 from $5.50 at Stifel
CBAY CymaBay
$6.90 /

+0.64 (+10.22%)

08/04/20 H.C. Wainwright
CymaBay price target raised to $13 from $9 at H.C. Wainwright
08/03/20 Cantor Fitzgerald
CymaBay price target raised to $20 from $15 at Cantor Fitzgerald
08/03/20 Piper Sandler
Street missing 'eye-catching' CymaBay data, says Piper Sandler
08/03/20 Stifel
CymaBay price target raised to $13 from $8 at Stifel
PXLW Pixelworks
$3.41 /

-0.045 (-1.30%)

02/07/20 Lake Street
Pixelworks upgraded to Buy from Hold at Lake Street
11/01/19 Lake Street
Pixelworks downgraded to Hold from Buy at Lake Street
BKD Brookdale Senior Living
$3.14 /

+0.125 (+4.15%)

09/03/19 Barclays
Brookdale Senior Living initiated with an Equal Weight at Barclays
OMER Omeros
$21.33 /

+7.2 (+50.96%)

03/04/20 Wedbush
Omeros price target raised to $22 from $18 at Wedbush
03/03/20 Cantor Fitzgerald
Omeros shares can 'significantly rerate' from here, says Cantor Fitzgerald
11/05/19 H.C. Wainwright
Omeros recent selloff appears unwarranted, says H.C. Wainwright
OXY Occidental Petroleum
$16.49 /

+1.04 (+6.73%)

08/04/20 Credit Suisse
Occidental Petroleum assumed with an Underperform at Credit Suisse
06/23/20 Barclays
Occidental Petroleum price target raised to $21 from $15 at Barclays
06/19/20 Truist
Occidental Petroleum upgraded to Buy from Hold at SunTrust
06/19/20 Mizuho
Occidental Petroleum price target raised to $18 from $13 at Mizuho
AKBA Akebia
$10.67 /

-0.27 (-2.47%)

05/15/20 Piper Sandler
Piper a buyer of Akebia shares to levels approaching $18
05/06/20 RBC Capital
Akebia price target raised to $12 from $8 at RBC Capital
05/05/20 Piper Sandler
Piper Sandler remains a buyer of Akebia following Phase 3 INNO2VATE data
05/05/20 Piper Sandler
Piper says efficacy, safety of FibroGen, Akebia drugs 'quite similar' in DD-CKD
QLYS Qualys
$113.09 /

-7.25 (-6.02%)

05/08/20 RBC Capital
Qualys price target raised to $101 from $85 at RBC Capital
05/01/20 Monness Crespi
Qualys downgraded to Neutral following outperformance at Monness Crespi
05/01/20 Monness Crespi
Qualys downgraded to Neutral from Buy at Monness Crespi
04/27/20 JMP Securities
Qualys downgraded to Market Perform from Outperform at JMP Securities
RAMP LiveRamp
$55.26 /

+1.765 (+3.30%)

07/09/20
Fly Intel: Top five analyst initiations
07/09/20 Craig-Hallum
LiveRamp initiated with a Buy at Craig-Hallum
05/22/20 Morgan Stanley
LiveRamp can reset expectations after guidance withdrawal, says Morgan Stanley
05/22/20 Susquehanna
LiveRamp price target raised to $60 from $50 at Susquehanna
HALO Halozyme
$28.66 /

-0.26 (-0.90%)

07/02/20 Piper Sandler
Halozyme price target raised to $31 from $28 at Piper Sandler
07/01/20 Benchmark
Benchmark starts Halozyme at Buy with $39 price target
07/01/20 Benchmark
Halozyme initiated with a Buy at Benchmark
06/29/20 Piper Sandler
Herceptin/Perjecta approval another win for Halozyme, says Piper
CHMA Chiasma
$4.78 /

+ (+0.00%)

07/07/20 Piper Sandler
Chiasma price target lowered to $19 from $22 at Piper Sandler
06/29/20 H.C. Wainwright
Chiasma price target raised to $11 from $10 at H.C. Wainwright
06/26/20 Piper Sandler
Chiasma price target raised to $22 from $13 at Piper Sandler
06/26/20 Cantor Fitzgerald
Chiasma approval a 'significant positive,' says Cantor Fitzgerald
ZI ZoomInfo
$43.28 /

-2.8 (-6.08%)

07/27/20 Mizuho
ZoomInfo recent selloff a buying opportunity, says Mizuho
06/30/20 Deutsche Bank
Deutsche starts ZoomInfo at Hold with shares double IPO price
06/29/20 Deutsche Bank
ZoomInfo initiated with a Hold at Deutsche Bank
06/29/20 JMP Securities
ZoomInfo initiated with a Market Perform at JMP Securities
IAC IAC
$131.08 /

-1.86 (-1.40%)

08/10/20 Jefferies
Jefferies says IAC stake in MGM fits history of being early to online shifts
08/10/20 Jefferies
Jefferies bullish on U.S. online gambling, sees $19B revenue opportunity
08/10/20 JPMorgan
IAC investment validates MGM opportunity in sports, online gaming, says JPMorgan
07/27/20 Jefferies
IAC price target raised to $155 from $150 at Jefferies
NSTG NanoString
$34.98 /

-0.26 (-0.74%)

05/11/20 Baird
NanoString price target raised to $34 from $29 at Baird
03/11/20 JPMorgan
JPMorgan continues to recommend select exposure to Life Science Tools
01/09/20 JPMorgan
Danaher, Thermo named JPMorgan's top 2020 picks in Life Science Tools
12/04/19 Lake Street
Veracyte answered key question with NanoString pact, says Lake Street
NVAX Novavax
$178.51 /

+8.54 (+5.02%)

08/06/20 Barclays
Moderna COVID vaccine still has 'best-in-class potential,' says Barclays
08/06/20 H.C. Wainwright
Novavax price target raised to $290 from $132 at H.C. Wainwright
08/05/20
Fly Intel: Top five analyst downgrades
08/05/20
Fly Intel: Top five analyst upgrades
SSTK Shutterstock
$57.06 /

-0.78 (-1.35%)

07/23/20 Needham
Shutterstock initiated with a Buy at Needham
11/05/19 Truist
Shutterstock price target raised to $38 from $36 at SunTrust
10/15/19 Jefferies
Jefferies selective on Internet into Q3, most positive on Alphabet and Facebook
BBBY Bed Bath & Beyond
$12.67 /

+0.55 (+4.54%)

07/10/20 Loop Capital
Bed Bath & Beyond price target raised to $9 from $5 at Loop Capital
07/07/20 Raymond James
Bed Bath & Beyond price target raised to $13 from $9 at Raymond James
05/26/20 Odeon Capital
Bed Bath & Beyond upgraded to Buy from Hold at Odeon Capital
04/16/20 Loop Capital
Bed Bath & Beyond Q4 results 'less bad than feared' says Loop Capital
ZI ZoomInfo
$43.28 /

-2.8 (-6.08%)

TME Tencent Music
$15.71 /

-0.305 (-1.91%)

TLRY Tilray
$7.97 /

+0.5 (+6.69%)

STAY Extended Stay America
$12.87 /

+0.12 (+0.94%)

SSTK Shutterstock
$57.06 /

-0.78 (-1.35%)

SPPI Spectrum
$3.91 /

+0.07 (+1.82%)

SCOR Comscore
$3.13 /

-0.21 (-6.29%)

RAMP LiveRamp
$55.26 /

+1.765 (+3.30%)

QRTEA Qurate Retail
$11.56 /

+0.02 (+0.17%)

QLYS Qualys
$113.09 /

-7.25 (-6.02%)

PXLW Pixelworks
$3.41 /

-0.045 (-1.30%)

PRTS CarParts.com
$13.71 /

+1.47 (+12.01%)

PFNX Pfenex
$7.68 /

-0.66 (-7.91%)

OXY Occidental Petroleum
$16.49 /

+1.04 (+6.73%)

OMER Omeros
$21.33 /

+7.2 (+50.96%)

NVAX Novavax
$178.51 /

+8.54 (+5.02%)

NSTG NanoString
$34.98 /

-0.26 (-0.74%)

NLS Nautilus
$12.36 /

+0.36 (+3.00%)

LGND Ligand
$118.48 /

+0.98 (+0.83%)

KFRC Kforce
$31.86 /

+1.14 (+3.71%)

JCOM j2 Global
$60.11 /

-1.32 (-2.15%)

IPAR Inter Parfums
$45.41 /

+1.73 (+3.96%)

ICUI ICU Medical
$179.40 /

+2.19 (+1.24%)

IART Integra LifeSciences
$49.42 /

+1.34 (+2.79%)

IAC IAC
$131.08 /

-1.86 (-1.40%)

HALO Halozyme
$28.66 /

-0.26 (-0.90%)

GSKY GreenSky
$6.35 /

+0.16 (+2.58%)

GO Grocery Outlet
$44.37 /

-0.57 (-1.27%)

CHMA Chiasma
$4.78 /

+ (+0.00%)

CBAY CymaBay
$6.90 /

+0.64 (+10.22%)

BKD Brookdale Senior Living
$3.14 /

+0.125 (+4.15%)

BBBY Bed Bath & Beyond
$12.67 /

+0.55 (+4.54%)

AKBA Akebia
$10.67 /

-0.27 (-2.47%)

  • 12
    Aug
  • 12
    Aug
  • 30
    Jul
  • 01
    Jul
  • 04
    Jun
  • 12
    May
  • 23
    Apr
  • 30
    Jan
  • 05
    Dec
  • 04
    Oct
TLRY Tilray
$7.97 /

+0.5 (+6.69%)

STAY Extended Stay America
$12.87 /

+0.12 (+0.94%)

SCOR Comscore
$3.13 /

-0.21 (-6.29%)

QLYS Qualys
$113.09 /

-7.25 (-6.02%)

OXY Occidental Petroleum
$16.49 /

+1.04 (+6.73%)

NVAX Novavax
$178.51 /

+8.54 (+5.02%)

BBBY Bed Bath & Beyond
$12.67 /

+0.55 (+4.54%)

AKBA Akebia
$10.67 /

-0.27 (-2.47%)

ZI ZoomInfo
$43.28 /

-2.8 (-6.08%)

TME Tencent Music
$15.71 /

-0.305 (-1.91%)

TLRY Tilray
$7.97 /

+0.5 (+6.69%)

STAY Extended Stay America
$12.87 /

+0.12 (+0.94%)

SPPI Spectrum
$3.91 /

+0.07 (+1.82%)

RAMP LiveRamp
$55.26 /

+1.765 (+3.30%)

QRTEA Qurate Retail
$11.56 /

+0.02 (+0.17%)

QLYS Qualys
$113.09 /

-7.25 (-6.02%)

PRTS CarParts.com
$13.71 /

+1.47 (+12.01%)

OXY Occidental Petroleum
$16.49 /

+1.04 (+6.73%)

NVAX Novavax
$178.51 /

+8.54 (+5.02%)

NLS Nautilus
$12.36 /

+0.36 (+3.00%)

LGND Ligand
$118.48 /

+0.98 (+0.83%)

JCOM j2 Global
$60.11 /

-1.32 (-2.15%)

IART Integra LifeSciences
$49.42 /

+1.34 (+2.79%)

IAC IAC
$131.08 /

-1.86 (-1.40%)

GSKY GreenSky
$6.35 /

+0.16 (+2.58%)

GO Grocery Outlet
$44.37 /

-0.57 (-1.27%)

CHMA Chiasma
$4.78 /

+ (+0.00%)

CBAY CymaBay
$6.90 /

+0.64 (+10.22%)

BBBY Bed Bath & Beyond
$12.67 /

+0.55 (+4.54%)

AKBA Akebia
$10.67 /

-0.27 (-2.47%)

TME Tencent Music
$15.71 /

-0.305 (-1.91%)

TLRY Tilray
$7.97 /

+0.5 (+6.69%)

QRTEA Qurate Retail
$11.56 /

+0.02 (+0.17%)

PRTS CarParts.com
$13.71 /

+1.47 (+12.01%)

OXY Occidental Petroleum
$16.49 /

+1.04 (+6.73%)

NVAX Novavax
$178.51 /

+8.54 (+5.02%)

IAC IAC
$131.08 /

-1.86 (-1.40%)

GO Grocery Outlet
$44.37 /

-0.57 (-1.27%)

CBAY CymaBay
$6.90 /

+0.64 (+10.22%)

BBBY Bed Bath & Beyond
$12.67 /

+0.55 (+4.54%)

Earnings
FreightCar America reports Q2 EPS (97c), two estimates (79c) » 19:08
08/10/20
08/10
19:08
08/10/20
19:08
RAIL

FreightCar America

$2.15 /

+0.13 (+6.44%)

Reports Q2 revenue…

Reports Q2 revenue $17.5M, two estimates $29.8M. The company had a backlog totaling 1,839 railcars on June 30, 2020, valued at approximately $207 million. CEO Jim Meyer: "The pandemic-related disruption further contributed to a difficult demand environment across our industry, which was already in the midst of a cyclical downtown. This further challenged both railcar orders and production scheduling during the second quarter. Of note, we had one additional week of operational downtime in our Shoals facility in the quarter as we halted production to protect the health and safety of our workforce. And while the recovery pattern remains opaque, we are encouraged by the recent improvement in order inquiries for car types that we are well suited to build. Our overall production ramped well through July, giving us confidence in our forecast for second half deliveries to range between 750 and 1,000 railcars. As we look forward, we remain equally focused on preserving our liquidity while also continuing to build the foundation for our future. We believe we are taking the right steps to navigate both the cyclical downturn and pandemic, while repositioning FreightCar America for future success."

ShowHide Related Items >><<
RAIL FreightCar America
$2.15 /

+0.13 (+6.44%)

Hot Stocks
Equinix buys India operations of GPX Global Systems for $161M » 19:06
08/10/20
08/10
19:06
08/10/20
19:06
EQIX

Equinix

$782.74 /

-9.26 (-1.17%)

Equinix announced its…

Equinix announced its expansion into India through the acquisition of the India operations of GPX Global Systems, Inc. The all-cash transaction value of $161M represents a multiple of approximately 15x the projected EBITDA at full utilization. The acquisition is expected to close in Q1 2021, subject to customary closing conditions including regulatory approval. Under the agreement, Equinix intends to acquire GPX India's business consisting of a fiber-connected campus in Mumbai with two data centers, adding more than 1,350 cabinets, with an additional 500 cabinets at full buildout. The facilities will add more than 90,000 square feet of colocation space to Platform Equinix when fully built.

ShowHide Related Items >><<
EQIX Equinix
$782.74 /

-9.26 (-1.17%)

EQIX Equinix
$782.74 /

-9.26 (-1.17%)

08/10/20 RBC Capital
Equinix price target raised to $845 from $706 at RBC Capital
08/06/20
Fly Intel: Top analyst initiations
08/06/20 TD Securities
Equinix initiated with a Hold at TD Securities
08/05/20 Deutsche Bank
Equinix price target raised to $850 from $760 at Deutsche Bank
EQIX Equinix
$782.74 /

-9.26 (-1.17%)

  • 12
    May
EQIX Equinix
$782.74 /

-9.26 (-1.17%)

EQIX Equinix
$782.74 /

-9.26 (-1.17%)

Upgrade
Mitsui & Co upgraded to Buy from Neutral at Goldman Sachs » 19:02
08/10/20
08/10
19:02
08/10/20
19:02
MITSY

Mitsui & Co

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Takashi Miyazaki upgraded Mitsui & Co to Buy from Neutral with a price target of 1,950 yen, up from 1,900 yen. The analyst believes that the stock looks undervalued after declining 6.8% from its June peak. Miyazaki also contends that the impact of COVID-19 on Mitsui is likely to be smaller than initially expected.

ShowHide Related Items >><<
MITSY Mitsui & Co
$0.00 /

+ (+0.00%)

06/18/20 SMBC Nikko
Mitsui & Co upgraded to Outperform from Neutral at SMBC Nikko
06/17/20 Goldman Sachs
Mitsui & Co downgraded to Neutral from Buy at Goldman Sachs
Hot Stocks
MVC Capital to merge into Barings BDC » 18:50
08/10/20
08/10
18:50
08/10/20
18:50
BBDC

Barings BDC

$8.29 /

+0.06 (+0.73%)

, MVC

MVC Capital

$6.76 /

+0.17 (+2.58%)

Barings BDC (BBDC) and…

Barings BDC (BBDC) and MVC Capital (MVC) have entered into a definitive merger agreement under which MVC Capital will merge with and into Barings BDC. The combined company, which will remain externally managed by Barings LLC, is expected to have more than $1.2B of investments on a pro forma basis. The transaction is expected to close in Q4. Under the merger agreement, MVC Capital stockholders will receive aggregate consideration of approximately $177.5M in the form of cash and stock consideration representing total book value consideration of $10.01 per fully diluted MVC Capital share. The transaction represents total consideration for MVC Capital stockholders of $145.5M or approximately $8.21 per share, representing a premium of 21% to MVC Capital's closing price on August 10. MVC Capital stockholders will receive 0.94024 Barings BDC shares for each MVC Capital share, resulting in approximately 16.7 million newly issued Barings BDC shares, having total value of $170.5M, or $9.62 per share. In addition, Barings LLC will pay approximately $7M in cash, or $0.39492 per share, directly to MVC Capital stockholders at closing. Following the Transaction, Barings BDC's equity base is expected to expand by $170M and Barings BDC stockholders and MVC Capital stockholders are expected to own approximately 74.2% and 25.8%, respectively, of the combined company. Barings BDC has agreed that, on the closing date, it will increase the size of its board of directors and cause one current member of the board of directors of MVC Capital, to be mutually selected by MVC Capital and Barings BDC to be appointed to the Barings BDC board of directors. MVC Capital will repay all outstanding amounts under its existing credit facilities and any remaining obligations thereunder will be terminated. In addition, in connection with the closing of the proposed Transaction, Barings BDC intends to redeem MVC Capital's 6.25% senior notes due November 30, 2022 with an aggregate principal amount outstanding of $95.0M. Barings BDC estimates NII per share to be 18c-20c in the first full quarter post-closing vs. 14c per share during Q2. Consummation of the transaction is subject to Barings BDC and MVC Capital stockholder approval, customary regulatory approvals and other closing conditions.

ShowHide Related Items >><<
MVC MVC Capital
$6.76 /

+0.17 (+2.58%)

BBDC Barings BDC
$8.29 /

+0.06 (+0.73%)

BBDC Barings BDC
$8.29 /

+0.06 (+0.73%)

06/24/20 Raymond James
Barings BDC upgraded to Strong Buy from Outperform at Raymond James
06/24/20 Raymond James
Barings BDC upgraded to Strong Buy from Outperform at Raymond James
05/04/20 Compass Point
Barings BDC upgraded to Buy following valuation markdowns at Compass Point
05/04/20 Compass Point
Barings BDC upgraded to Buy from Neutral at Compass Point
MVC MVC Capital
$6.76 /

+0.17 (+2.58%)

03/25/20 Maxim
PennantPark, Garrison Capital, MVC Capital cut to Hold at Maxim
03/25/20 Maxim
MVC Capital downgraded to Hold from Buy at Maxim
BBDC Barings BDC
$8.29 /

+0.06 (+0.73%)

Hot Stocks
Inseego CEO: Highly secure products are in our DNA » 18:43
08/10/20
08/10
18:43
08/10/20
18:43
INSG

Inseego

$12.79 /

+0.71 (+5.88%)

In an interview on…

In an interview on CNBC's Mad Money, Dan Mondor said Q2 was exceptional with the highest revenue in recent history. "We see it as a surge and not a temporary spike," he noted. Mondor said the company maintains a significant amount of customers in banking and government agencies.

ShowHide Related Items >><<
INSG Inseego
$12.79 /

+0.71 (+5.88%)

INSG Inseego
$12.79 /

+0.71 (+5.88%)

08/06/20
Fly Intel: Top five analyst downgrades
08/06/20 Lake Street
Inseego price target raised to $17 from $13 at Lake Street
08/06/20 Roth Capital
Inseego downgraded to Neutral on valuation at Roth Capital
08/06/20 Northland
Inseego downgraded to Market Perform on valuation at Northland
INSG Inseego
$12.79 /

+0.71 (+5.88%)

INSG Inseego
$12.79 /

+0.71 (+5.88%)

INSG Inseego
$12.79 /

+0.71 (+5.88%)

Hot Stocks
Support.com appoints Lance Rosenzweig as CEO » 18:41
08/10/20
08/10
18:41
08/10/20
18:41
SPRT

Support.com

$1.60 /

-0.04 (-2.44%)

Support.com has elected…

Support.com has elected Lance Rosenzweig to succeed Rick Bloom as President and CEO as of August 10. Rick will step down as CEO following four years with the company. To ensure a seamless transition, Rick will continue as Support.com's Principal Financial Officer for the next few months and will remain an active member of the company's Board of Directors. Lance Rosenzweig has served as CEO of Startek, Aegis USA, and PeopleSupport, which he co-founded.

ShowHide Related Items >><<
SPRT Support.com
$1.60 /

-0.04 (-2.44%)

Hot Stocks
Quidel says Maryland allows point-of-care testing for COVID-19 » 18:39
08/10/20
08/10
18:39
08/10/20
18:39
QDEL

Quidel

$229.16 /

-44 (-16.11%)

Quidel Corporation…

Quidel Corporation announced that the State of Maryland has allowed point-of-care testing for COVID-19. The Maryland Department of Health has allowed point-of-care testing for COVID-19, stating: "Any healthcare provider or healthcare facility, subject to certain terms and conditions, may perform COVID-19 point-of-care (POC) test analysis pursuant to Executive Order 20-03-23-02." The order is effective August 10, 2020. Under the new directive, Maryland residents who believe they should be tested can now contact their healthcare provider, who can order a "COVID-19 test for any individual who believes it necessary, regardless of symptoms."

ShowHide Related Items >><<
QDEL Quidel
$229.16 /

-44 (-16.11%)

QDEL Quidel
$229.16 /

-44 (-16.11%)

07/31/20 Craig-Hallum
Quidel price target raised to $363 from $306 at Craig-Hallum
07/31/20 Piper Sandler
Quidel price target raised to $360 from $250 at Piper Sandler
07/08/20 Piper Sandler
Quidel price target raised to $250 from $168 at Piper Sandler
07/07/20 Craig-Hallum
Quidel price target raised to $306 from $170 at Craig-Hallum
QDEL Quidel
$229.16 /

-44 (-16.11%)

QDEL Quidel
$229.16 /

-44 (-16.11%)

Hot Stocks
GreenSky up over 10% at $7.00 per share after Q2 earnings beat  18:08
08/10/20
08/10
18:08
08/10/20
18:08
GSKY

GreenSky

$6.35 /

+0.16 (+2.58%)

 
ShowHide Related Items >><<
GSKY GreenSky
$6.35 /

+0.16 (+2.58%)

GSKY GreenSky
$6.35 /

+0.16 (+2.58%)

05/13/20 Truist
GreenSky price target lowered to $4 from $7 at SunTrust
05/13/20 Citi
GreenSky price target lowered to $3.50 from $4.50 at Citi
03/18/20 Citi
GreenSky downgraded to Sell from Neutral at Citi
GSKY GreenSky
$6.35 /

+0.16 (+2.58%)

GSKY GreenSky
$6.35 /

+0.16 (+2.58%)

Earnings
Nutrien cuts FY20 adjusted EPS view to $1.50-$1.90 from $1.50-$2.10 » 18:07
08/10/20
08/10
18:07
08/10/20
18:07
NTR

Nutrien

$36.67 /

+1.26 (+3.56%)

Cuts FY20 adjusted EBITDA…

Cuts FY20 adjusted EBITDA view to $3.5B-$3.8B from $3.5B-$3.9B. The top end of the guidance range was lowered due to lower ammonia and UAN prices.

ShowHide Related Items >><<
NTR Nutrien
$36.67 /

+1.26 (+3.56%)

NTR Nutrien
$36.67 /

+1.26 (+3.56%)

07/13/20
Fly Intel: Top five analyst upgrades
07/13/20 BofA
Nutrien, CF Industries, Corteva double-upgraded to Buy from Underperform at BofA
07/13/20 BofA
Nutrien upgraded to Buy from Underperform at BofA
06/19/20 JPMorgan
Nutrien price target lowered to $40 from $44 at JPMorgan
NTR Nutrien
$36.67 /

+1.26 (+3.56%)

NTR Nutrien
$36.67 /

+1.26 (+3.56%)

NTR Nutrien
$36.67 /

+1.26 (+3.56%)

Earnings
Nutrien reports Q2 diluted EPS $1.34 vs. $1.47 a year ago » 18:04
08/10/20
08/10
18:04
08/10/20
18:04
NTR

Nutrien

$36.67 /

+1.26 (+3.56%)

Reports Q2 revenue $8.42B…

Reports Q2 revenue $8.42B vs. $8.69B a year ago. Reports Q2 adjusted EPS $1.45.

ShowHide Related Items >><<
NTR Nutrien
$36.67 /

+1.26 (+3.56%)

NTR Nutrien
$36.67 /

+1.26 (+3.56%)

07/13/20
Fly Intel: Top five analyst upgrades
07/13/20 BofA
Nutrien, CF Industries, Corteva double-upgraded to Buy from Underperform at BofA
07/13/20 BofA
Nutrien upgraded to Buy from Underperform at BofA
06/19/20 JPMorgan
Nutrien price target lowered to $40 from $44 at JPMorgan
NTR Nutrien
$36.67 /

+1.26 (+3.56%)

NTR Nutrien
$36.67 /

+1.26 (+3.56%)

NTR Nutrien
$36.67 /

+1.26 (+3.56%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.